Rubric Capital Management (New York)’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,101,886
| Closed | -$28.9M | – | 85 |
|
|
2025
Q3 | $28.9M | Buy |
5,101,886
+499,909
| +11% | +$2.56M | 0.39% | 50 |
|
|
2025
Q2 | $17.5M | Sell |
4,601,977
-173,023
| -4% | -$537K | 0.28% | 53 |
|
|
2025
Q1 | $12.6M | Hold |
4,775,000
| – | – | 0.23% | 50 |
|
|
2024
Q4 | $16.9M | Hold |
4,775,000
| – | – | 0.31% | 52 |
|
|
2024
Q3 | $21.8M | Buy |
4,775,000
+1,250,000
| +35% | +$6.05M | 0.36% | 46 |
|
|
2024
Q2 | $15.3M | Hold |
3,525,000
| – | – | 0.4% | 48 |
|
|
2024
Q1 | $17.7M | Buy |
3,525,000
+25,000
| +0.7% | +$140K | 0.52% | 49 |
|
|
2023
Q4 | $21.9M | Buy |
3,500,000
+786,713
| +29% | +$4.51M | 0.82% | 36 |
|
|
2023
Q3 | $19.3M | Buy |
2,713,287
+1,901,770
| +234% | +$15M | 0.81% | 36 |
|
|
2023
Q2 | $8.27M | Buy |
+811,517
| New | +$8.47M | 0.35% | 49 |
|